Lilly CEO David Ricks keeps eye on future while company celebrates history
The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.
Health Care & Life Sciences
Corteva to keep its headquarters in Indianapolis post-split
Corteva, which is planning to split into two publicly traded companies later this year, announced Tuesday that the crop protection part of its business will continue to be based in Indianapolis.
Food partnership, life sciences speaker series unveiled at Lilly’s 150th anniversary event
Former Indianapolis Colts quarterback Peyton Manning emceed the event, which took place before about 500 attendees at the new Lilly Event Center in downtown Indianapolis.
Corteva still mulling post-split headquarters decisions
Indianapolis-based agricultural giant Corteva, which plans to separate into two independent companies, said it hasn’t yet decided where the companies will be based.
Lilly announces additional $4.5B investment at LEAP District manufacturing site
Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.
Corteva announces name of new seed and genetics company
In October, Corteva’s board of directors unanimously approved a plan to separate the company’s crop protection business and its seed business into two independent companies.
2026 Innovation Issue: Entrepreneur Richard DiMarchi stays locked in as the market for blockbuster drugs evolves
| 
Lesley Weidenbener and
Lesley Weidenbener and Richard DiMarchi still works a full schedule, researching and teaching at Indiana University.
2026 Innovation Issue: Don Brown launches Bioscope.AI
The serial entrepreneur also launched the affiliated Longevity Today, a website that identifies, processes and summarizes life sciences research and offers information to the public through AI personas.
Lilly earnings increase as Mounjaro, Zepbound sales continue rise
The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.
Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine
The Indianapolis-based drugmaker will partner with Profluent to develop and commercialize treatments for diseases with severe unmet needs.
Lilly acquiring cancer-drug firm Ajax Therapeutics in deal worth up to $2.3B
The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.
Complex process leads to a new drug’s identity
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.
Central Indiana excelling in life sciences, but it needs a brand, speakers say
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.
Q&A: Cardiologist has spent career working on treatment for rare condition
Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley Children’s Health, has been working on a treatment for a neurodegenerative condition called Friedreich’s ataxia for decades.
IU, Zimmer Biomet forge 3-year partnership to advance orthopedic sector
The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.
Community Health Network Foundation names new CEO
Derek B. Groves will join Community Health Network Foundation in May as part of a planned leadership transition. He will succeed longtime CEO Joyce Irwin.
Ossium Health aims to revolutionize role of bone marrow banks
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
Greene County hospital serves Anthem with breach notice over underpayments
Hospital CEO Brenda Reetz the insurance underpayment situation impacts patient bills, hospital stability and access to care. Indianapolis-based Anthem said it is working with the hospital to resolve the problem.
Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies
Through the collaboration, Telix and Regeneron expect to develop and commercialize next-generation radiopharmaceutical therapies targeting cancer.
Corteva names CEO for ‘New Corteva’ crop protection spinoff
Luke Kissam will lead New Corteva after Corteva officially separates its pesticide and seed businesses into two independent, publicly traded companies.